PAC's Ag stocks | Pretty's picks | MedAdvisor's Euro Deal
About this video
Paul Jensz, Ag stock analyst at PAC Partners, highlights opportunities in the agricultural sector beyond weather and commodity risks. He emphasises the growth of agtech companies and gatekeepers, enhancing sector prospects. Jens discusses investments in promising companies like Digital Agriculture Services (DAS) and Elders (ELD), noting the trend of unlisted companies in agri food, fiber, and energy, requiring broader investment strategies.
Martin Pretty from Equitable Investments discusses the AGM season's impact on stocks, noting more downgrades than upgrades in their 'fit universe' of financials, industrials, and technology companies. He highlights prevalent inflation pressures and fluctuating consumer spending affecting various sectors. Martin also addresses MedAdvisor's (MDR) strong trading update and Intelligent Monitoring Group's (IMB) promising turnaround, providing an optimistic outlook amidst challenges in small-cap investing.
Rick Ratliff, CEO of MedAdvisor ( MDR) discusses their significant growth due to the continued expansion of their vaccine and chronic medication programmes in the United States, as well as steady growth in Australia and New Zealand. The addition of approximately 1400 new pharmacies to MedAdvisor's network following their acquisition of the Gild Link pharmacies has contributed to the growth, most notably in their health program expansions. Rick also assures that MedAdvisor is anticipating to finish the 2023 calendar year with a strong cash position of around $20 million. Regarding global operations, Rick shares that the company manages communication of medication-related content to patients through their community pharmacy in the US and UK. In their strategic alignment with Charac Limited, MedAdvisor anticipates accelerating their market penetration in the UK thanks to Charac's momentum with independent pharmacies. With the two companies sharing a strategy of leveraging pharmacy-driven patient engagement, Rick envisions a rapid development of the UK market, and eventually, the introduction of Charac technology in the US as well.